Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Valeant seeks to become top 5 pharmaceutical company -CEO
Yahoo/Reuters
Tuesday, January 7, 2014 - 10:09am
tags:
Valeant Pharmaceuticals, J. Michael Pearson, Pharma CEOs
Progenics Likely To Announce Positive Prostate Cancer Data In January
Seeking Alpha
Tuesday, January 7, 2014 - 9:28am
tags:
prostate cancer, Progenics, Celldex Therapeutics, Seattle Genetics, CytRx, Adcetris
Lilly issues 2014 forecast in line with Wall St estimates
Yahoo/Reuters
Tuesday, January 7, 2014 - 9:27am
tags:
Eli Lilly
Gilead Sales Chief Retires Amidst Key Hep C Drug Launch, Massive Insider Selling
TheStreet.com
Tuesday, January 7, 2014 - 9:26am
tags:
Gilead Sciences, hepatitis C, Sovaldi
Pluristem's Positive Data Could Open Massive Muscle Injury Market
Seeking Alpha
Tuesday, January 7, 2014 - 9:24am
tags:
Pluristem Therapeutics, Stryker, JNJ, Zimmer, hip recall, PLX cell therapy
Obesity Stocks Focus on Approvals As Arena Pharmaceuticals Goes Global
TheStreet.com
Monday, January 6, 2014 - 7:26pm
tags:
drug approvals, Arena Pharmaceuticals, obesity, GSK, Orexigen, Belviq, Eisai
Neurocrine Biosciences shares surge on study
Marketwatch
Monday, January 6, 2014 - 4:58pm
tags:
tardive dyskinesia, Neurocrine Biosciences, NBI-98854
FDA returns for look at risk of Boehringer Ingelheim's Pradaxa
Fierce Pharma
Monday, January 6, 2014 - 4:53pm
tags:
Pradaxa, FDA, Boehringer Ingelheim, bloodthinners
Intercept to Provide Update on Pipeline
Yahoo/Zacks.com
Monday, January 6, 2014 - 4:49pm
tags:
Intercept Pharma, primary biliary cirrhosis
Three biopharma companies poised for product OKs in 2014: analyst
Marketwatch
Monday, January 6, 2014 - 4:34pm
tags:
Cubist, Regeneron, Spectrum
This FDA Letter About Sarepta and Accelerated Approval for Eteplirsen Will Blow Your Mind
TheStreet.com
Monday, January 6, 2014 - 4:25pm
tags:
FDA, Sarepta Therapeutics, Duchenne Muscular Dystrophy, eteplirsen
Is Cell Therapeutics Turning Over A New Leaf In 2014?
Wall St Cheat Sheet
Monday, January 6, 2014 - 11:51am
tags:
Cell Therapeutics, tosedostat
Cancer Drug Royalties: Celgene Battles Boston Hospital
Wall St Cheat Sheet
Monday, January 6, 2014 - 11:45am
tags:
Celgene
Semantics 101: Goldman’s Biotech Downgrade and the New Biotech Consensus
Barron's
Monday, January 6, 2014 - 11:44am
tags:
biotech, Amgen, Regeneron
J&J's Synthes wins round in spat with ex-sales rep
Mass Device
Monday, January 6, 2014 - 11:05am
tags:
devices, JNJ, Synthes
Is the audience listening? FDA wants to spy on social media to find out
Fierce Pharma
Monday, January 6, 2014 - 11:03am
tags:
FDA, social media
India - An important Market for Mylan
Yahoo/Zacks.com
Monday, January 6, 2014 - 10:57am
tags:
India, Mylan
FIT Biotech to begin HIV vaccine trial in spring 2014
Pharmaceutical Business Review
Monday, January 6, 2014 - 9:59am
tags:
HIV, FIT Biotech, vaccines
The Surprising Way Big Pharma Is Researching New Drugs
Motley Fool
Monday, January 6, 2014 - 9:58am
tags:
Amgen, R&D
BrainStorm Cell Therapeutics says stem cells helped patient with ALS and MG
Reuters
Monday, January 6, 2014 - 9:55am
tags:
ALS, BrainStorm Cell Therapeutics, stem cells, myasthenia gravis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.